Exenatide circular RNA-Lipid Nanoparticle Injection (CR059)

Exenatide circular RNA-Lipid Nanoparticle Injection · The First Affiliated Hospital of Henan University of Science and Technology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Exenatide circular RNA-Lipid Nanoparticle Injection (CR059), covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus [EARLY_Phase 1]

See pricing